BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10643010)

  • 1. Detection of false-negative Papanicolaou smears by rapid rescreening in a large routine cervical cytology laboratory.
    Wright RG; Halford JA; Ditchmen EJ
    Pathology; 1999 Nov; 31(4):379-81. PubMed ID: 10643010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid rescreening of cervical smears: an improved method of quality control.
    Dudding N
    Cytopathology; 1995 Apr; 6(2):95-9. PubMed ID: 7795170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
    Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
    Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the PAPNET cytologic screening system for quality control of cervical smears.
    Koss LG; Lin E; Schreiber K; Elgert P; Mango L
    Am J Clin Pathol; 1994 Feb; 101(2):220-9. PubMed ID: 8116579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural-network-assisted analysis and microscopic rescreening in presumed negative cervical cytologic smears. A comparison.
    Mango LJ; Valente PT
    Acta Cytol; 1998; 42(1):227-32. PubMed ID: 9479345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of PAPNET: review of 25,656 Pap smears negative on manual screening and rapid rescreening.
    Halford JA; Wright RG; Ditchmen EJ
    Cytopathology; 1999 Oct; 10(5):317-23. PubMed ID: 10588350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of false negative rates between 100% rapid review and 10% random full rescreening as internal quality control methods in cervical cytology screening.
    Lee BC; Lam SY; Walker T
    Acta Cytol; 2009; 53(3):271-6. PubMed ID: 19534266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
    Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
    Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assurance in cervical smears: 100% rapid rescreening vs. 10% random rescreening.
    Amaral RG; Zeferino LC; Hardy E; Westin MC; Martinez EZ; Montemor EB
    Acta Cytol; 2005; 49(3):244-8. PubMed ID: 15966284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved quality-control detection of false-negative Pap smears using the Autopap 300 QC system.
    Marshall CJ; Rowe L; Bentz JS
    Diagn Cytopathol; 1999 Mar; 20(3):170-4. PubMed ID: 10086244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid rescreening of cervical smears for internal quality control.
    Diehl AR; Prolla JC
    Acta Cytol; 1998; 42(4):949-53. PubMed ID: 9684583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The PAPNET system in the rescreening of negative cervical/vaginal smears. A study from the Imola cytology laboratory].
    Ghidoni D; Fabbris E; Folicaldi S; Amadori A; Medri M; Bucchi L; Bondi A
    Pathologica; 1998 Aug; 90(4):357-63. PubMed ID: 9793395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-Negative Rate of Papanicolaou Testing: A National Survey from the Thai Society of Cytology.
    Koonmee S; Bychkov A; Shuangshoti S; Bhummichitra K; Himakhun W; Karalak A; Rangdaeng S
    Acta Cytol; 2017; 61(6):434-440. PubMed ID: 28738387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in the routine screening of cervical smears: A study using rapid prescreening and 100% rapid review as internal quality control methods.
    Tavares SB; Alves de Sousa NL; Manrique EJ; Pinheiro de Albuquerque ZB; Zeferino LC; Amaral RG
    Cancer Cytopathol; 2011 Dec; 119(6):367-76. PubMed ID: 21954191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAPNET-assisted rescreening of cervical smears: cost and accuracy compared with a 100% manual rescreening strategy.
    O'Leary TJ; Tellado M; Buckner SB; Ali IS; Stevens A; Ollayos CW
    JAMA; 1998 Jan; 279(3):235-7. PubMed ID: 9438746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of PAPNET system for rescreening of negative cervical smears.
    Ashfaq R; Liang Y; Saboorian MH
    Diagn Cytopathol; 1995 Jul; 13(1):31-6. PubMed ID: 7587873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: I. A prospective intended use study.
    Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
    Cancer; 1997 Dec; 81(6):337-42. PubMed ID: 9438458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
    Djemli A; Khetani K; Auger M
    Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant reduction in the rate of false-negative cervical smears with neural network-based technology (PAPNET Testing System).
    Koss LG; Sherman ME; Cohen MB; Anes AR; Darragh TM; Lemos LB; McClellan BJ; Rosenthal DL; Keyhani-Rofagha S; Schreiber K; Valente PT
    Hum Pathol; 1997 Oct; 28(10):1196-203. PubMed ID: 9343327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of false negative Pap smears by rapid reviewing. A metaanalysis.
    Arbyn M; Schenck U
    Acta Cytol; 2000; 44(6):949-57. PubMed ID: 11127751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.